Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04316715 · ClinicalTrials.gov registry record · NA

Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care

A NA study of Adherence, Medication, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT04316715 is a NA study of Adherence, Medication that has completed, run by University of Miami. The registered enrollment target is 300 participants, below the 814-participant average among 13 other Adherence, Medication trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04316715, a NA study of Adherence, Medication, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to test how different types of interventions may affect how someone takes their pre-exposure prophylaxis (PrEP) medication.

Conditions Studied

Interventions

  • BEHAVIORAL Lifesteps for PrEP
  • BEHAVIORAL Daily text message reminders

Study Locations (2)

Florida

  • University of Miami - Miami

Massachusetts

  • Fenway Health - Boston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2020-09-03
Est. Completion 2025-08-01
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT04316715

The ClinicalTrials.gov registry entry for NCT04316715 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 814-participant average among 13 other Adherence, Medication trials with a reported enrollment target (63% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adherence, Medication appearing as the primary indexed condition, and to 2 interventions - of which Lifesteps for PrEP is the first listed.

NCT04316715 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04316715 about?

NCT04316715 is a clinical study titled "Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care". The purpose of this study is to test how different types of interventions may affect how someone takes their pre-exposure prophylaxis (PrEP) medication.

What is the current status of trial NCT04316715?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2020-09-03. Estimated completion is 2025-08-01.

What conditions does trial NCT04316715 study?

This clinical trial studies the following conditions: Adherence, Medication.

What interventions are being tested in trial NCT04316715?

The interventions under investigation include: Lifesteps for PrEP (BEHAVIORAL), Daily text message reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT04316715?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04316715 being conducted?

This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adherence, Medication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.